Dillon Patterson

Immunology Drug Discovery @JnanaTx | previously CRI Fellow @Harvardmed in the lab of Dr. Arlene H. Sharpe & PhD from @EmoryUniversity in @JBossLab

[Dillon Patterson @DG_Patterson]

@Gap ready to sponsor omg so cute

[David R. Liu @davidrliu]

Today in @Nature we report a new prime editing strategy that can rescue a common cause of many genetic diseases in a disease-agnostic manner. This approach converts a redundant endogenous tRNA into an optimized suppressor tRNA, enabling a single prime edit to rescue premature stop codons across different diseases.
(1/15)
https://t.co/zs0qu5bhXx

[Martin LaFleur @MartinLaFleur18]

Excited to share our paper in
@NatImmunol! Using in vivo #CRISPR screens we identify the E3 ligase STUB1 as a new cancer immunotherapy target in CD8 T cells. STUB1 is a dual function target: STUB1 KO promotes CD8 responses and STUB1 KO hinders tumor cells. https://t.co/NitHcvkuNc

[James SeongJun Han, PhD @jameshan_sj]

Our aging manuscript is finally out in the November issue @CIR_AACR! Check out if you are interested in understanding how aging impact anti-tumor immunity and response to anti-PD1 ICB! #aging #Tcell

[Dr. Anita Corbett- (She/her) 🏳️‍🌈 @acorbe2]

https://t.co/xnExKxwiFq
Emory Biology @emorycollege is hiring! We invite applications for a tenure track Asst Prof position in the area of epigenetics, including chromatin biology, nuclear organization, cellular differentiation, development, and/or gene regulation. Please share!

[Jnana Therapeutics @jnanatx]

We’re proud to share that Jnana is now part of Otsuka Pharmaceutical Co. and will operate as a direct subsidiary in Boston. We look forward to continuing our R&D efforts and advancing JNT-517 into a Ph 3 pivotal study for #PKU in 2025. https://t.co/UQK7yuwqdz

#biotech

[Jnana Therapeutics @jnanatx]

Today, we shared positive results from the Ph 1/2 clinical trial of JNT-517 in adults with phenylketonuria (PKU).

Based on these results, we plan to advance JNT-517 directly into a pivotal Ph 3 study in early 2025. More: https://t.co/BbSwOwKIsZ #clinicaltrials #SSIEM #SSIEM2024

[William J. Greenleaf @WJGreenleaf]

The Greenleaf lab is looking to recruit graduate students and postdocs interested in combinatorial cell state engineering. If you are interested combining multiplex perturbations and single cell readouts to "push" cells into target states, email Will!

[Dillon Patterson @DG_Patterson]

Congratulations to the entire Jnana team. Looking forward to working with our new colleagues!

[Jnana Therapeutics @jnanatx]

Jnana announced today that it has entered into an agreement to be acquired by Otsuka Pharmaceutical.
https://t.co/IMXvbxYwaE #biotech #news

[Dillon Patterson @DG_Patterson]

The supplemental video for Figure 6 with the custom soundtrack absolutely made my Saturday hahaha 😂. Wondering if the fastball didn’t change the loops if a Juan Soto or Aaron Judge swing would…

Congrats to you and your team.

[Juan A. Rodríguez @jrotwitguez]

It’s finally out! 🥳 Today @cellcellpress we report non-mineral fossils of ancient chromosomes in skin from a woolly mammoth that died in Siberia, 52,000 years ago.
🦣💨
Don’t miss our thread below! 🧵👇🏽

[Dillon Patterson @DG_Patterson]

Amazing paper and thread

[Adrian Liston @LabListon]

Biggest paper yet from the lab out now in @ImmunityCP! It is a massive #openscience resource on #tissueTregs, and what makes #Tregs tick in the #tissues. Spoiler-alert: Tissue Tregs are really different from what we all thought. 🧵 1/21

https://t.co/k8q7LhMewB

[Dillon Patterson @DG_Patterson]

@Satpathology Incredible team

[Dillon Patterson @DG_Patterson]

Awesome ! @Satpathology looking forward to following the progress

[Ansu Satpathy @Satpathology]

Happy to share what we’ve been building at Santa Ana Bio! Immunotherapies that precisely target immune cell types underlying autoimmune disease with a goal of bringing three new antibodies to clinical trials next year. Congratulations to Peter Emtage and the SAB team, and has been so wonderful to partner with close friends and colleagues Sasha Rudensky, @FlavellLab, Graham Lord, Danny Wells, @JerelDavis13, Brendan Bulik-Sullivan, @vintweeta, Shin Fuse

[Ansu Satpathy @Satpathology]

Happy to share what we’ve been building at Santa Ana Bio! Immunotherapies that precisely target immune cell types underlying autoimmune disease with a goal of bringing three new antibodies to clinical trials next year. Congratulations to Peter Emtage and the SAB team, and has been so wonderful to partner with close friends and colleagues Sasha Rudensky, @FlavellLab, Graham Lord, Danny Wells, @JerelDavis13, Brendan Bulik-Sullivan, @vintweeta, Shin Fuse

[Brian Miller @BrianC_Miller]

Always fun to see great science from great labs (and great friends). @DebattamaSen https://t.co/k2AztGpxsE

[Dillon Patterson @DG_Patterson]

Thank you @jnanatx for sending a congratulatory gift for our new addition to our family - Baby Graham! Great place to work for exciting science with amazing talented people!

[Dillon Patterson @DG_Patterson]

New addition to our family! Alexandria and I couldn’t be more excited !

[Jason M Schenkel @JMSchenkel]

Does anyone happen to have or know anyone who has a chst4 cre or cre-ert2 or cdh5 cre-ert2 in the united states that would be willing to share? Please retweet 🙏!!!

[Cancer Research Institute @CancerResearch]

Congratulations to Dr. Gordon Freeman @DanaFarber @harvardmed, who was awarded with the prestigious @AACR- Cancer Research Institute Lloyd J. Old Award in Cancer Immunology at the annual American Association for Cancer Research meeting! Discover: https://t.co/kE848FwT16 #AACR24

[Dillon Patterson @DG_Patterson]

@Katz_Lab @emorygmb @neurophd_emory Way to go Monica Reeves - fellow South Alabama / Borchert lab alum